Publication
Abstract
Design of a part of a clinical trial called Double-blind, randomized, placebo-controlled, parallel-group study oromukosálního stpreje Sativex (Sativex, Nabiximol) administered for pain relief in patients with advanced cancer who are at an optimized chronic opioid therapy do not experience sufficient anaalgetický effect